James S Scibetta is Director of Matinas BioPharma Holdings, Inc.. Currently has a direct ownership of 649,958 shares of MTNB, which is worth approximately $402,973. The most recent transaction as insider was on Jun 19, 2021, when has been sold 24,000 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 650K
0% 3M change
0% 12M change
Total Value Held $402,973

James S Scibetta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 19 2021
BUY
Conversion of derivative security
-
24,000 Added 3.56%
649,958 Common Stock, par valu...
Jun 19 2021
BUY
Other acquisition or disposition
-
4,800 Added 0.76%
625,958 Common Stock, par valu...

Also insider at

AQST
Aquestive Therapeutics, Inc. Healthcare
JSS

James S Scibetta

Director
Bedminster,, NJ

Track Institutional and Insider Activities on MTNB

Follow Matinas BioPharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTNB shares.

Notify only if

Insider Trading

Get notified when an Matinas Bio Pharma Holdings, Inc. insider buys or sells MTNB shares.

Notify only if

News

Receive news related to Matinas BioPharma Holdings, Inc.

Track Activities on MTNB